The emerging role of soluble HLA-G in the control of chemotaxis

Fabio Morandi; Nathalie Rouas-Freiss; Vito Pistoia

doi:10.1016/j.cytogfr.2014.04.004

The emerging role of soluble HLA-G in the control of chemotaxis

Fabio Morandi, Nathalie Rouas-Freiss, Vito Pistoia

Istituto "Giannina Gaslini"

Research output: Contribution to journal › Article

Abstract

HLA-G is an immunosuppressive molecule, that impairs the function of different immune cell populations, both in physiological and pathological conditions. Here, we have analyzed data obtained by our group and others regarding sHLA-G concentration in plasma from patients with different diseases. Next, we have summarized novel data regarding the impairment of chemotaxis of different immune effector cells mediated by sHLA-G. Finally, we have discussed the impact of this function on the immune response during cancer, viral infection, autoimmunity, and on B cell differentiation in secondary lymphoid organs. In conclusion, we have delineated a role of sHLA-G in the control of chemotaxis of immune effector cells, that may be relevant to modulate immune responses in different settings.

Original language	English
Pages (from-to)	327-335
Number of pages	9
Journal	Cytokine and Growth Factor Reviews
Volume	25
Issue number	3
DOIs	https://doi.org/10.1016/j.cytogfr.2014.04.004
Publication status	Published - 2014

Fingerprint

Keywords

Chemokine receptors
Chemotaxis
HLA-G

ASJC Scopus subject areas

Immunology
Endocrinology, Diabetes and Metabolism
Immunology and Allergy
Biochemistry, Genetics and Molecular Biology(all)
Medicine(all)

Cite this

Morandi, F., Rouas-Freiss, N., & Pistoia, V. (2014). The emerging role of soluble HLA-G in the control of chemotaxis. Cytokine and Growth Factor Reviews, 25(3), 327-335. https://doi.org/10.1016/j.cytogfr.2014.04.004

@article{d24aba945c5e4193878175bcb4ba761d,

title = "The emerging role of soluble HLA-G in the control of chemotaxis",

abstract = "HLA-G is an immunosuppressive molecule, that impairs the function of different immune cell populations, both in physiological and pathological conditions. Here, we have analyzed data obtained by our group and others regarding sHLA-G concentration in plasma from patients with different diseases. Next, we have summarized novel data regarding the impairment of chemotaxis of different immune effector cells mediated by sHLA-G. Finally, we have discussed the impact of this function on the immune response during cancer, viral infection, autoimmunity, and on B cell differentiation in secondary lymphoid organs. In conclusion, we have delineated a role of sHLA-G in the control of chemotaxis of immune effector cells, that may be relevant to modulate immune responses in different settings.",

keywords = "Chemokine receptors, Chemotaxis, HLA-G",

author = "Fabio Morandi and Nathalie Rouas-Freiss and Vito Pistoia",

year = "2014",

doi = "10.1016/j.cytogfr.2014.04.004",

language = "English",

volume = "25",

pages = "327--335",

journal = "Cytokine and Growth Factor Reviews",

issn = "1359-6101",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - The emerging role of soluble HLA-G in the control of chemotaxis

AU - Morandi, Fabio

AU - Rouas-Freiss, Nathalie

AU - Pistoia, Vito

PY - 2014

Y1 - 2014

N2 - HLA-G is an immunosuppressive molecule, that impairs the function of different immune cell populations, both in physiological and pathological conditions. Here, we have analyzed data obtained by our group and others regarding sHLA-G concentration in plasma from patients with different diseases. Next, we have summarized novel data regarding the impairment of chemotaxis of different immune effector cells mediated by sHLA-G. Finally, we have discussed the impact of this function on the immune response during cancer, viral infection, autoimmunity, and on B cell differentiation in secondary lymphoid organs. In conclusion, we have delineated a role of sHLA-G in the control of chemotaxis of immune effector cells, that may be relevant to modulate immune responses in different settings.

AB - HLA-G is an immunosuppressive molecule, that impairs the function of different immune cell populations, both in physiological and pathological conditions. Here, we have analyzed data obtained by our group and others regarding sHLA-G concentration in plasma from patients with different diseases. Next, we have summarized novel data regarding the impairment of chemotaxis of different immune effector cells mediated by sHLA-G. Finally, we have discussed the impact of this function on the immune response during cancer, viral infection, autoimmunity, and on B cell differentiation in secondary lymphoid organs. In conclusion, we have delineated a role of sHLA-G in the control of chemotaxis of immune effector cells, that may be relevant to modulate immune responses in different settings.

KW - Chemokine receptors

KW - Chemotaxis

KW - HLA-G

UR - http://www.scopus.com/inward/record.url?scp=84902077948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902077948&partnerID=8YFLogxK

U2 - 10.1016/j.cytogfr.2014.04.004

DO - 10.1016/j.cytogfr.2014.04.004

M3 - Article

C2 - 24882150

AN - SCOPUS:84902077948

VL - 25

SP - 327

EP - 335

JO - Cytokine and Growth Factor Reviews

JF - Cytokine and Growth Factor Reviews

SN - 1359-6101

IS - 3

ER -

Access to Document

10.1016/j.cytogfr.2014.04.004